Effect of cisplatin and other biological response modifiers on the activity of lysozyme, plasminogen activator and 5' nucleotidase by murine macrophages in vitro.
In vitro effect of cisplatin and other biological response modifiers has been studied. It is observed that in vitro treatment of macrophage monolayers with cisplatin, rIFN Y, LPS or MDP either alone or in combination showed significantly increased activity of lysozyme, plasminogen activator and decreased activity of 5' nucleotidase. Priming of macrophages with rIFN Y had a significant effect in enhancing the activity of lysozyme and plasminogen activator when subsequently treated with cisplatin, MDP or LPS.
Geetha
B
B
Department of Zoology, Banaras Hindu University, Uttar Pradesh, India.
Sodhi
A
A
D015720:5'-Nucleotidase / Q000378:metabolism*; D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology; D000818:Animals; D002945:Cisplatin / Q000494:pharmacology*; D007155:Immunologic Factors / Q000494:pharmacology*; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008262:Macrophage Activation; D008264:Macrophages / Q000201:enzymology*; D051379:Mice; D008809:Mice, Inbred C3H; D009113:Muramidase / Q000378:metabolism*; D010960:Plasminogen Activators / Q000378:metabolism*; D011994:Recombinant Proteins
D007155:Immunologic Factors; D008070:Lipopolysaccharides; D011994:Recombinant Proteins; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D007371:Interferon-gamma; D015720:5'-Nucleotidase; D009113:Muramidase; D010960:Plasminogen Activators; D002945:Cisplatin